R. Bowen

607 total citations
7 papers, 459 citations indexed

About

R. Bowen is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. Bowen has authored 7 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 2 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. Bowen's work include Attention Deficit Hyperactivity Disorder (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Bipolar Disorder and Treatment (2 papers). R. Bowen is often cited by papers focused on Attention Deficit Hyperactivity Disorder (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Bipolar Disorder and Treatment (2 papers). R. Bowen collaborates with scholars based in Canada, United States and China. R. Bowen's co-authors include Stephanie L. Barnes, Hong Wei, Qiuyin Cai, Yan Wang, David Bakish, J. D’Souza, Peter H. Yu, Kenneth E. Carlson, Alan A. Boulton and Girish M. Mody and has published in prestigious journals such as Psychiatry Research, Acta Psychiatrica Scandinavica and Experimental Biology and Medicine.

In The Last Decade

R. Bowen

7 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Bowen Canada	5	298	101	94	94	90	7	459
Natalie J Thatcher United Kingdom	12	211 0.7×	101 1.0×	104 1.1×	77 0.8×	126 1.4×	15	505
Herman Adlercreutz Finland	7	387 1.3×	214 2.1×	93 1.0×	168 1.8×	151 1.7×	7	621
J. B. Howes Australia	12	474 1.6×	283 2.8×	77 0.8×	107 1.1×	308 3.4×	18	680
Wannit Tongkao‐on Australia	10	168 0.6×	36 0.4×	88 0.9×	68 0.7×	29 0.3×	13	425
Donald G. Matthews United States	11	255 0.9×	70 0.7×	107 1.1×	88 0.9×	40 0.4×	19	631
Stephan Teyssen Germany	13	119 0.4×	27 0.3×	142 1.5×	105 1.1×	118 1.3×	36	713
Tracy D'Alessandro United States	6	154 0.5×	58 0.6×	112 1.2×	61 0.6×	77 0.9×	6	382
A.L. Bhatia India	10	104 0.3×	32 0.3×	111 1.2×	51 0.5×	47 0.5×	26	507
G. C. Descovich Italy	12	149 0.5×	40 0.4×	131 1.4×	164 1.7×	122 1.4×	17	521
Hikmet Öz Türkiye	7	101 0.3×	26 0.3×	71 0.8×	45 0.5×	40 0.4×	7	426

Countries citing papers authored by R. Bowen

Since Specialization

Citations

This map shows the geographic impact of R. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bowen more than expected).

Fields of papers citing papers by R. Bowen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bowen. The network helps show where R. Bowen may publish in the future.

Co-authorship network of co-authors of R. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Bowen. A scholar is included among the top collaborators of R. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Bowen. R. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wei, Zhao, Christine Lavoie, Jacob Cohen, et al.. (2019). Low-Field Magnetic Stimulation (LFMS) decreases cuprizone-induced cognitive impairment and brain pathology in mice. European Neuropsychopharmacology. 29. S227–S228. 1 indexed citations

2.

Wei, Hong, R. Bowen, Qiuyin Cai, Stephanie L. Barnes, & Yan Wang. (1995). Antioxidant and Antipromotional Effects of the Soybean Isoflavone Genistein. Experimental Biology and Medicine. 208(1). 124–130. 403 indexed citations

3.

Bowen, R., et al.. (1993). Effect of lithium dosing schedule on urinary output. Acta Psychiatrica Scandinavica. 87(2). 92–95. 13 indexed citations

4.

Bakish, David, et al.. (1993). Reversible monoamine oxidase-A inhibitors in panic disorder.. PubMed. 16 Suppl 2. S77–82. 19 indexed citations

5.

Bakish, David, et al.. (1992). BROFAROMINE AND CLOMIPRAMINE IN PANIC DISORDER: A DOUBLE-BLIND STUDY.. Clinical Neuropharmacology. 15. 60B–60B. 3 indexed citations

6.

Mody, Girish M., et al.. (1984). Amyloidosis at Groote Schuur Hospital, Cape Town.. PubMed. 66(2). 47–9. 4 indexed citations

7.

Yu, Peter H., et al.. (1982). Comparison of biochemical properties of platelet monoamine oxidase in mentally disordered and healthy individuals. Psychiatry Research. 6(1). 107–121. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact